Evidence map›Paper›PMID 22095946›Full record

ArticleJournal of the American Society of Nephrology : JASN2012

Mannose receptor 2 attenuates renal fibrosis.

Jesús M López-Guisa, Xiaohe Cai, Sarah J Collins, Ikuyo Yamaguchi, Daryl M Okamura, Thomas H Bugge, Clare M Isacke, Claire L Emson, Scott M Turner, Stuart J Shankland and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of the American Society of Nephrology : JASN, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 74 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Fibrosis in Immune-Mediated and Autoimmune Disorders.Journal of clinical medicine · 2025
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. uPARAP/Endo180: a multifaceted protein of mesenchymal cells.Cellular and molecular life sciences : CMLS · 2022
    Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. You Say You Want a Resolution (of Fibrosis).American journal of respiratory cell and molecular biology · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 2 countries.

Jesús M López-GuisaSeattle Children's Research Institute and Department of Pediatrics, University of Washington, Seattle, WA 98101-1309, USA.
Xiaohe Cai
Sarah J Collins
Ikuyo Yamaguchi
Daryl M Okamura
Thomas H Bugge
Clare M Isacke
Claire L Emson
Scott M Turner
Stuart J Shankland
Allison A Eddy
University of Washington · USKineMed (United States) · USBreast Cancer Now · GBNational Institute of Dental and Craniofacial Research · USSeattle Children's Hospital · US

Funding

Cell surface serine proteases in development, tissue repair, and malignancyZIADE000699 · NIDCR · NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH · PI BUGGE, THOMAS H · 2009 to 2025
$34.1M
ROLE OF SCAVENGER RECEPTORS IN RENAL FIBROSISP50DK044757 · NIDDK · VANDERBILT UNIVERSITY · PI FOGO, AGNES B. · 1992 to 2011
$11.5M
Washington University Center for Kidney Disease ResearchP30DK079333 · NIDDK · WASHINGTON UNIVERSITY · PI HAMMERMAN, MARC RANDALL · 2007 to 2011
$5.1M
MOLECULAR MECHANISMS IN RENAL INTERSTITIAL FIBROSISR01DK054500 · NIDDK · SEATTLE CHILDREN'S HOSPITAL · PI EDDY, ALLISON AUDREY · 1999 to 2008
$2.8M
MOLECULAR MECHANISMS OF HEPATITIS B VIRAL PATHOGENESIS AND PERSISTENCEZ01DK054500 · NIDDK · NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES · PI LIANG, T. JAKE · 1997 to 2008
$927k
Microvascular Endothelial Cells in the Pathogenesis of Chronic Kidney InjuryK08DK080926 · NIDDK · SEATTLE CHILDREN'S HOSPITAL · PI YAMAGUCHI, IKUYO · 2008 to 2011
$652k
Multifunctional role CD36 in progressive renal fibrosisK08DK073497 · NIDDK · SEATTLE CHILDREN'S HOSPITAL · PI OKAMURA, DARYL MIYOSHI · 2006 to 2009
$514k
Breast Cancer Now BREAST CANCER NOW RESEARCH CENTREIntramural NIH HHS Z01 DK054500NIDDK NIH HHS DK073497NIDDK NIH HHS DK080926NIDDK NIH HHS DK44757NIDDK NIH HHS K08 DK073497NIDDK NIH HHS K08 DK080926NIDDK NIH HHS P30 DK079333NIDDK NIH HHS P30DK079333NIDDK NIH HHS P50 DK044757NIDDK NIH HHS R01 DK054500
6 · The paper itself

Abstract

Mannose receptor 2 (Mrc2) expresses an extracellular fibronectin type II domain that binds to and internalizes collagen, suggesting that it may play a role in modulating renal fibrosis. Here, we found that Mrc2 levels were very low in normal kidneys but subsets of interstitial myofibroblasts and macrophages upregulated Mrc2 after unilateral ureteral obstruction (UUO). Renal fibrosis and renal parenchymal damage were significantly worse in Mrc2-deficient mice. Similarly, Mrc2-deficient Col4α3(-/-) mice with hereditary nephritis had significantly higher levels of total kidney collagen, serum BUN, and urinary protein than Mrc2-sufficient Col4α3(-/-) mice. The more severe phenotype seemed to be the result of reduced collagen turnover, because procollagen III (α1) mRNA levels and fractional collagen synthesis in the wild-type and Mrc2-deficient kidneys were similar after UUO. Although Mrc2 associates with the urokinase receptor, differences in renal urokinase activity did not account for the increased fibrosis in the Mrc2-deficient mice. Treating wild-type mice with a cathepsin inhibitor, which blocks proteases implicated in Mrc2-mediated collagen degradation, worsened UUO-induced renal fibrosis. Cathepsin mRNA profiles were similar in Mrc2-positive fibroblasts and macrophages, and Mrc2 genotype did not alter relative cathepsin mRNA levels. Taken together, these data establish an important fibrosis-attenuating role for Mrc2-expressing renal interstitial cells and suggest the involvement of a lysosomal collagen turnover pathway.

Indexed as

AnimalsAutoantigensChronic DiseaseCollagenCollagen Type IVFibrosisKidneyKidney DiseasesMacrophagesMembrane GlycoproteinsMiceMice, Inbred C57BLMyofibroblastsReceptors, Cell SurfaceUreteral ObstructionAutoantigensCollagenCollagen Type IVMembrane GlycoproteinsMrc2 protein, mouseReceptors, Cell Surfacetype IV collagen alpha3 chain

Identifiers

PMID22095946
PMCPMC3269177
OpenAlexW2155602138

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.